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The defensive skin secretions of amphibians are a rich source of bioactive peptides. Here we describe a rapid technique for skin granular gland
transcriptome cloning from a surrogate tissue—the secretion itself. cDNA libraries were constructed from lyophilized skin secretion from each of
the Chinese frogs (Rana schmackeri, Rana versabilis, and Rana plancyi fukienensis) using magnetic oligo(dT) bead-captured polyadenylated
mRNA as templates. Specific esculentin cDNAs were amplified by 3′-RACE using a degenerate primer designed for a consensus nucleotide
sequence in the 5′ untranslated region of previously characterized ranid frog peptide cDNAs. The cloned cDNAs were found to encode the
antimicrobial peptides esculentins 1 and 2 from each of the species examined. The presence of predicted peptide structures in skin secretions was
confirmed by MALDI-TOF mass spectrometry and automated Edman degradation. This experimental approach can thus rapidly expedite parallel
transcriptome and peptidome analysis of amphibian granular gland secretions without harming or sacrificing donor animals.
© 2005 Elsevier Inc. All rights reserved.Keywords: Amphibian; Skin secretion; Mass spectrometry; Peptide; CloningIn its morphology, biochemistry, and physiology, amphibian
skin is a complex organ that performs the wide range of
functions necessary for amphibian survival [1,2]. The defensive
secretions produced by the specialized tegumental granular
glands are complex cocktails of bioactive molecules with
peptides predominating in most species. These have been the
subject of intense research interest for many years from both
academic and pharmaceutical groups due to their potential
applications in biophysical research, biochemical taxonomy,
and lead compound development for new pharmaceuticals,☆ Sequence data from this article have been deposited with the EMBL Data
Library under Accession Nos. AJ968397 to AJ968402 (respectively esculentin-
1S and esculentin-2S from the skin of the Chinese frog Rana plancyi
fukienensis, esculentin-1V and esculentin-2V from R. schmackeri, and
esculentin-1P and esculentin-2P from R. versabilis).
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[3,4].
During the past decade, the emergence of multiple-drug-
resistant strains of many pathogenic micro-organisms has
stimulated the search for new classes of antimicrobial
compounds that may have clinical applications [5]. Among
these potential new leads are a group that has received
increasing attention—the broad-spectrum antimicrobial poly-
peptides that are synthesized in and secreted from amphibian
skin [1–3,6]. The presence of such peptides in defensive skin
secretions represents an important feature of the defense
strategy of these vertebrates against micropredator attack and
some authors believe that they constitute the frontline barrier
of a primitive cell-free immune system [7,8]. Although
antimicrobial peptides have been identified in the secretions
of many species from different frog taxa (bombinins from
Bombina toads, magainins from Xenopus, and dermaseptins
from Phyllomedusa leaf frogs), frogs of the genus Rana,
which contains an estimated 250 species with an essentially
Fig. 1. Translated nucleic acid sequences of cloned cDNAs encoding frog skin antimicrobial peptides—esculentins 1P, 1S, 1V, 2P, 2S, and 2V. Putative signal peptides
are double underlined, mature peptides are single –underlined, and stop codons are indicated by asterisks.
639T. Chen et al. / Genomics 87 (2006) 638–644worldwide distribution, represent one of the groups that have
been subjected to the most focused study [9]. At least 36
species from this taxon are found in North America alone
[10]. Of the peptides possessing antimicrobial activity isolated
from these species, several main families can be identified on
a primary structural similarity basis [9]. These include the
esculentins (originally from Rana esculenta—the European
edible frog) [11], the brevinins (originally from Rana
brevipoda porsa—an Asiatic pond frog) [12], the ranatuerins
(originally from Rana catesbeiana—the American bullfrog)
[13], and the temporins (originally from Rana temporaria—
the European common frog) [14]. The esculentins contain the
greatest number of amino acid residues and are typically theFig. 2. Domain architecture of preproesculentins. (1) Putative signal peptide. (2) Acid
Mature peptide. Fully conserved amino acid residues within each group are indicated b
esculentin precursor for comparison in the EMBL and NCBI databases.most potent of the antimicrobial peptides found in skin
secretions [11]. Frogs of the genus Litoria have been
subjected to a similar close scrutiny of antimicrobial skin
peptides by Bowie and Tyler's group in Adelaide, Australia,
but this taxon is effectively limited to the Australasian
zoogeographical region [15].
Here, we report the application of a recently developed
technique within our laboratory to “shotgun” clone esculentin
1A and 2A homolog precursor cDNAs from the lyophilized
skin secretions (the “surrogate” tissues) of three species of
Chinese frogs, Rana schmackeri, Rana versabilis, and Rana
plancyi fukienensis. Deduction of the molecular masses of each
mature processed peptide from respective cloned cDNAs wasic “spacer” peptide. (3) KR (Lys-Arg) propeptide convertase processing site. (4)
y asterisks. [11] Reference for esculentin 1B from R. esculenta—the only cloned
Fig. 3. Regions of reverse-phase HPLC chromatograms of respective frog skin secretions, (A) R. plancyi fukienensis, (B) R. schmackeri, and (C) R. versabilis,
indicating the retention times (arrows) of individual esculentins 1 and 2.
640 T. Chen et al. / Genomics 87 (2006) 638–644used to locate respective molecules in reverse-phase HPLC
fractions of secretion. Finally, their primary structures were
confirmed by either automated Edman degradation or MS/MS
fragmentation. The peptides were named in accordance withpreviously established nomenclature as esculentin-1S (S,
schmackeri), esculentin-1V (V, versabilis), and esculentin-1P
(P, plancyi) and esculentin-2S, esculentin-2V, and esculentin-
2P, respectively.
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Shotgun cloning of esculentin cDNAs
Two novel peptide cDNAs were consistently cloned from
each species skin secretion library and each encoded a single
copy of a novel esculentin-related peptide (Fig. 1). An EBI-
BLAST search found that the nucleotide sequences of
esculentin-1S, esculentin-1V, and esculentin-1P showed at
least 90% sequence identity, respectively, with the original
esculentin-1 sequence from R. esculenta [11]. However, the
structure and organization of R. esculenta precursor cDNA
remain unreported and hence such comparisons could not be
made. The conserved preproregion of each esculentin precursor
open reading frame includes a putative 22-amino-acid-residue
signal peptide followed by an acidic peptide that terminates in a
typical Lys-Arg (KR) propeptide convertase processing motif
that is responsible for cleavage and release of each respective
mature peptide located at the C-terminal (Fig. 2).
Isolation and structural characterization of esculentins
Following prediction of the molecular mass of each novel
esculentin from the cloned precursors and compensation for
posttranslational modification (single disulfide bridge forma-
tion in the C-terminal loop, −2 amu), each mature peptide was
identified in respective skin secretion HPLC fractions (Figs. 3
and 4). Primary structures were confirmed by either automated
Edman degradation or MS/MS (data not shown). The NCBI
BLAST search found that the novel esculentins 1 and 2 from all
three species showed at least 90 and 70% sequence identity,
respectively, with esculentins 1 and 2 from R. esculenta (Fig. 5)
[11]. An interesting observation was that esculentin-1P from R.
plancyi fukienensis was completely identical to esculentin-1A
from R. esculenta. This parallels the finding of caerulein in the
skin of Litoria caerulea (Hylidae) and Xenopus laevis (Pipidae)
[1].
Antimicrobial activity of novel esculentins
The quantities of esculentins recovered from each species
following transdermal electrical stimulation ranged between 12
and 15 nmol/mg of lyophilized skin secretion as determined by
amino acid analysis. Esculentin-1 peptides were consistently
more abundant (two- to fourfold) than esculentin-2 peptides in
each species. The minimal inhibitory concentrations (MICs)
obtained for each peptide against Staphylococcus aureus (FDA
209P) and Escherichia coli (ATCC 25922) are summarized inFig. 4. Primary structures of esculentins established by a combination of automated Ed
mature peptides from respective secretion fractions are indicated.Table 1. Each novel peptide was found to be less potent than the
original R. esculenta esculentin [11] by a consistent factor of
about 1 order of magnitude. However, these data were more
comparable to data obtained for esculentins from other species
of Rana frogs investigated more recently that illustrated a high
degree of variation in potency [9,16].
Discussion
Amphibian defensive skin secretions remain a largely
unexplored source for discovery of novel bioactive peptides
with a high potential as novel drug leads for many diseases [1–
4]. Of particular interest and the subjects of the most intense
research focus in these molecular libraries have been the broad-
spectrum antimicrobial peptides that have activity against
many multiple-drug-resistant human pathogens [5]. However,
like many areas of drug discovery that require a source of
natural materials from what is often threatened biodiversity,
there are several inherent problems to overcome. Amphibians
are in rapid global decline such that this research is time
limited and acquisition of materials from already endangered
herpetofauna is ethically and morally questionable. To
overcome these major obstacles it was necessary to develop
techniques that were ethically acceptable, on one hand, for
acquisition of materials and, on the other hand, that permitted
rapid and high-throughput proteomic (peptidomic) and ge-
nomic data capture without compromising data robustness. The
gentle transdermal electrical stimulation technique developed
by the Tyler et al. [17] in Australia solved the problem of
noninvasive, nonlethal acquisition of skin secretions for
proteomic (peptidomic) analyses. However, these studies on
skin secretion polypeptides and proteins, often an important
prerequisite to understanding their functional pharmacology,
can be a long-term project using conventional protein
chemistry. In contrast, transcriptome cDNA cloning studies
can potentially effect much more rapid primary structural
characterization (and perhaps establishment of microstructural
diversity) of these polypeptides and proteins. Likewise,
establishment of precursor cDNA sequence may give clues
(such as encoded C-terminal amidation motifs) that can
facilitate deduction of final, posttranslationally processed
products. Our group first demonstrated that the transcriptomes
of the secretion-producing skin granular glands were present in
stimulated secretions as well as being preserved during the
lyophilization process [18]. Until now, while isolation and
structural characterization of proteins/peptides could be
achieved using lyophilized skin secretion, construction of
cDNA libraries for the purpose of molecular cloning ofman degradation and mass spectrometry. The observed and calculated masses of
Table 1
Minimal inhibitory concentrations (in μM) of novel esculentins against a gram-
positive bacterium (Staphylococcus aureus) and a gram-negative bacterium
(Escherichia coli)
Staphylococcus aureus Escherichia coli
Esculentin-1S 3.0 1.7
Esculentin-1V 4.9 3.2
Esculentin-1P 4.3 2.8
Esculentin-2S 2.6 1.1
Esculentin-2V 4.4 2.8
Esculentin-2P 2.2 0.9
Esculentin-1E a 0.4 0.2
Esculentin-2E a 0.8 0.4
Esculentin-2L a 3.0 6.0
Esculentin-2B a 1.0 1.0
Cecropin A 1.5 3.0
Ampicillin 1.5 15.0
Esculentins 1S and 2S from Rana schmackeri, esculentins 1V and 2V from R.
versabilis, and esculentins 1P and 2P from R. plancyi fukienensis.
a Esculentins 1E and 2E from the European edible frog, R. esculenta [11],
and esculentins 2L and 2B from the North American frogs R. luteiventris and R.
berlandieri [16], respectively, for comparison. The antimicrobial peptide
cecropin A and the broad-spectrum antibiotic ampicillin were included as
positive controls.
Fig. 5. Comparison of amino acid sequences of esculentins identified in the present study with those previously identified in R. esculenta (1A, 1B, and 2B). Identical
amino acid residues in each group of mature peptides are indicated by asterisks.
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followed by removal of skin. These procedures thus made it
extremely difficult to perform both aspects of study on the
same specimens and made it impossible to perform sequential
experiments in time. While it is acknowledged that the
presence of mRNA in a particular tissue does not necessarily
mean that a given protein/peptide is expressed there, the
parallel identification of both transcript and translate in the
same biological specimen attributes extreme scientific robust-
ness to the present data. The data also unequivocally attest to
the fact that the sacrifice of frogs for skin cDNA library
construction, hitherto regarded as a sine qua non for the
cloning of granular gland secretion components, is unnecessary
and that generation of appropriate molecular genetic data is not
compromised but rather facilitated. Once a suitably sized data
set has been generated from several frog species spanning
several different families, it is possible to design primers to
highly conserved nucleic acid sequence domains in 5′
nontranslated regions of peptide precursor cDNAs that prime
3′-RACE reactions within skin secretion-derived libraries from
new, unstudied species. This rapidly generates nucleic acid
sequences that encode secretory peptide open reading frames.
This was the method employed in the present study to illustrate
the robustness of this approach.
By this method, the cDNAs encoding the esculentin
precursors were rapidly obtained from libraries constructed
from lyophilized skin secretion samples of three unstudied
species of Chinese ranid frogs. The esculentin propeptide
convertase cleavage sites in each case (classical KR motifs)
were readily identified, enabling deduction of putative
molecular masses of encoded peptides. The 46-amino-acid-
residue peptide, esculentin-1, and the 37-amino-acid-residue
peptide, esculentin-2, were first isolated from the skin of
European frogs belonging to the R. esculenta complex, but
the peptides have subsequently been identified in North
American frogs [11]. Here, we report for the first time
cloning and identification of a family of novel preproescu-
lentin cDNAs from skin secretions of three Chinese frogs—
R. schmackeri, R. versabilis, and R. plancyi fukienensis. A
significant feature of the present study regards the NCBI
BLAST search. Esculentin precursors show high homology
to the antimicrobial peptides from different Rana species,
such as brevinins, esculentins, and ranalexin [9,19].Additionally, the open reading frame nucleotide sequences
of the novel peptide cDNAs encoding the putative signal
peptide and the first 3 residues of the acidic spacer peptide
domain share about 50–75% identity with the corresponding
regions of antimicrobial peptide cDNAs from other amphib-
ian groups. These include the caerins, dermaseptins,
brevinins, temporins, and gaegurin cDNAs [19]. This finding
reinforces the hypothesis that one exon encoding the signal
peptide of several otherwise unrelated peptide precursors
was present early in the evolution of the Amphibia. The
duplication and recombinational events that promoted the
association of such a homologous secretory exon, with
nucleotide sequences coding for a variety of end products in
various amphibian species, remain to be elucidated but are
likely to have occurred at the very early stages of species
radiation.
A preliminary study of the antimicrobial potency of the novel
natural esculentins using standard gram-positive and gram-
negative laboratory bacterial models established a range of
MICs from 0.9 to 4.9 μM that is consistent with those
643T. Chen et al. / Genomics 87 (2006) 638–644previously in the literature (0.2 to 6.0 μM) for structural
homologs obtained from other Rana species [9]. Esculentins are
evidently among the most potent of frog skin antimicrobial
peptides, with esculentin-1 peptides being among the most
highly conserved of frog skin antimicrobials, whereas escu-
lentin-2 peptides are among the most poorly-conserved [9].
However, due to their low hemolytic activity they have been
considered to be the most likely group for commercial
exploitation. Indeed, a transgenic tobacco plant (Nicotiana
tabacum), expressing a gene encoding an esculentin-1 analog,
displayed significantly enhanced resistance to pathogenic
bacteria and insects [20].
However, the structural and the related functional
differences of amphibian skin antimicrobial peptides, even
within a single species that possesses multiple isomeric
forms of broad-spectrum actives such as esculentins, may be
suggestive of a naturally selected mechanism directed
toward generating maximum possible microbicidal effects
while simultaneously minimizing generation of resistance
mechanisms. This is in effect the natural application of
combination therapy that we now know should provide both
of these highly desirable endpoints most effectively. Such
strategies, as have evolved in nature subject to eons of
selection pressures, should be more critically evaluated for
therapeutic drug design and the application of the simple
genomic approach described here should provide a more
rapid, nondestructive approach to achieving this goal.
Materials and methods
Specimen biodata and secretion harvesting
R. schmackeri, R. versabilis, and R. plancyi fukienensis (n = 3,
respectively) were captured during expeditions in the People's Republic of
China. R. schmackeri were caught in Wuyishan National Park, Fujian; R.
versabilis at Five Fingers Peak National Nature Reserve, Hainan Island; and
R. plancyi fukienensis in the vicinity of Fuzhou City, Fujian. All frogs were
adults and secretion harvesting was performed in the field after which frogs
were released. Skin secretion was obtained from the dorsal skin using
gentle transdermal electrical stimulation as previously described [17]. The
stimulated secretions were washed from the skin using deionized water and
divided into either 0.2% v/v aqueous trifluoroacetic acid (for subsequent
peptide characterization) or cell lysis/mRNA stabilization buffer (Dynal) for
subsequent cDNA library construction.
Shotgun cloning of esculentin cDNAs
Polyadenylated mRNA was isolated from stabilization buffer using
magnetic oligo(dT) beads as described by the manufacturer (Dynal Biotech,
UK) and reverse-transcribed. The cDNA was subjected to 3′-RACE
procedures to obtain full-length preproesculentin nucleic acid sequence
data using a SMART-RACE kit (Clontech UK) essentially as described by
the manufacturer. Briefly, the 3′-RACE reactions employed a NUP primer
(supplied with the kit) and a degenerate sense primer (S1: 5′-
GAWYYAYYHRAGCCYAAADATG-3′) that was designed to a highly
conserved domain of the 5′ untranslated region of previously-characterized
esculentin cDNAs from Rana species [11,19]. The PCR cycling procedure
was as follows: initial denaturation step, 60 s at 94°C; 35 cycles of
denaturation 30 s at 94°C, primer annealing for 30 s at 53°C; and
extension for 180 s at 72°C. PCR products were gel-purified, cloned using
a pGEM-T vector system (Promega Corp.), and sequenced using an ABI
3100 automated sequencer.Identification and structural analyses of deduced esculentin homologs
The acidified skin secretion washings were clarified of microparticulates by
centrifugation. The clear supernatant was then pumped directly onto a reverse-
phase HPLC column and subjected to LC/MS using a gradient formed from 0.05/
99.5 (v/v) TFA/water to 0.05/19.95/80.0 (v/v/v) TFA/water/acetonitrile in 240
min at a flow rate of 1 ml/min. A Thermoquest gradient reversed-phase HPLC
system, fitted with an analytical column (C-18 for R. plancyi fukienensis and C-5
for other frogs) and interfaced with a Thermoquest LCQ electrospray ion-trap
mass spectrometer was employed. The effluent from the chromatographic
column was flow-split with approximately 10% entering the mass spectrometer
source and 90% directed toward a fraction collector. Dead volume between
column and fraction collector was minimal (20 μl). The molecular masses of
polypeptides in each chromatographic fraction were further analyzed using
matrix-assisted laser desorption/ionization, time-of-flight mass spectrometry on
a linear time-of-flight Voyager DE mass spectrometer (Perseptive Biosystems,
MA,USA) in positive detectionmode usingα-cyano-4-hydroxycinnamic acid as
the matrix. Internal mass calibration of the instrument with known standards
established the accuracy of mass determination as ±0.1%. The peptides with
masses coincident with those of esculentin as deduced from cloned precursor
cDNAs were each subjected to primary structural analysis by automated Edman
degradation using an Applied Biosystems 491 Procise sequencer in pulsed-liquid
mode or by MS/MS fragmentation sequencing using the LCQ.
Antimicrobial activity of novel esculentins
Each novel esculentin homolog was purified to homogeneity from initial
fractions by a second reverse-phase HPLC fractionation with collection of the
major absorbance peak by hand. Each fraction was adjusted to a volume of 1
ml with 0.05/99.5 (v/v) TFA/water, and a sample (50 μl) was removed,
lyophilized, and subjected to amino acid analysis using a standard acid
hydrolytic procedure. Once each natural peptide had been quantified, the
original fractions were lyophilized prior to establishment of MICs using a
standard gram-positive bacterium (S. aureus—FDA 209P) and a standard
gram-negative bacterium (E. coli—ATCC 25922). Lyophilized samples of
each novel esculentin were initially reconstituted in 200 μl of sodium
phosphate-buffered saline, pH 7.2. MICs for each peptide against both test
organisms were assessed by incubating peptides in nutrient broth following
inoculation with 50 μl (containing 104 colony-forming units) from overnight
standard cultures into 96-well microtiter cell culture plates. Plates were
incubated for 18 h at 37°C in a humidified atmosphere. Following this, the
growth of bacteria was determined by means of measuring absorbance at λ
550 nm using a microtiter plate reader (MA Bioproducts, Model MA308).
MICs were taken as the lowest concentration of peptides in which no visible
growth was observed. Positive controls employed included cecropin A—an
antimicrobial peptide from insect hemolymph (Sigma)—and ampicillin—a
broad-spectrum β-lactam antibiotic (Bristol–Myers–Squibb).Acknowledgments
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